PAVmed Valuation
| PAVM Stock | USD 0.60 0.05 9.09% |
PAVmed is overvalued. PAVmed Inc holds a recent Real Value of $0.54 per share. The prevailing price of the entity is $0.6. Our model determines the value of PAVmed Inc from inspecting the entity fundamentals such as Profit Margin of 37.12 %, return on asset of -0.5, and Shares Outstanding of 17.29 M as well as reviewing its technical indicators and probability of bankruptcy.
Price Book 0.5122 | Enterprise Value 44.4 M | Enterprise Value Ebitda 0.6702 | Price Sales 4.81 | Trailing PE 0.1602 |
Overvalued
Today
Please note that PAVmed's price fluctuation is abnormally volatile at this time. Calculation of the real value of PAVmed Inc is based on 3 months time horizon. Increasing PAVmed's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the PAVmed stock is determined by what a typical buyer is willing to pay for full or partial control of PAVmed Inc. Since PAVmed is currently traded on the exchange, buyers and sellers on that exchange determine the market value of PAVmed Stock. However, PAVmed's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.6 | Real 0.54 | Target 11.75 | Hype 0.6 | Naive 0.56 |
The intrinsic value of PAVmed's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence PAVmed's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of PAVmed Inc helps investors to forecast how PAVmed stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of PAVmed more accurately as focusing exclusively on PAVmed's fundamentals will not take into account other important factors: PAVmed Cash |
|
PAVmed Total Value Analysis
PAVmed Inc is at this time anticipated to have valuation of 44.4 M with market capitalization of 9.59 M, debt of 31.86 M, and cash on hands of 68.47 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the PAVmed fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
44.4 M | 9.59 M | 31.86 M | 68.47 M |
PAVmed Investor Information
About 22.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.51. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. PAVmed Inc had not issued any dividends in recent years. The entity had 1:15 split on the 7th of December 2023. Based on the measurements of operating efficiency obtained from PAVmed's historical financial statements, PAVmed Inc is not in a good financial situation at this time. It has a very high probability of going through financial hardship in August.PAVmed Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. PAVmed has an asset utilization ratio of 9.77 percent. This suggests that the Company is making $0.0977 for each dollar of assets. An increasing asset utilization means that PAVmed Inc is more efficient with each dollar of assets it utilizes for everyday operations.PAVmed Ownership Allocation
PAVmed owns a total of 17.29 Million outstanding shares. PAVmed Inc has noticeable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company maintains, if the real value of the entity is less than the current market value, you may not be able to make money on it.PAVmed Profitability Analysis
The company reported the previous year's revenue of 3 M. Net Income was 28.43 M with loss before overhead, payroll, taxes, and interest of (1.14 M).About PAVmed Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of PAVmed Inc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of PAVmed Inc based exclusively on its fundamental and basic technical indicators. By analyzing PAVmed's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of PAVmed's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of PAVmed. We calculate exposure to PAVmed's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of PAVmed's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -3 M | -2.9 M |
PAVmed Growth Indicators
Investing in growth stocks can be very risky. If the company such as PAVmed does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 65.3 M |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PAVmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PAVmed. If investors know PAVmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PAVmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 3.46 | Revenue Per Share 0.182 | Quarterly Revenue Growth (0.99) | Return On Assets (0.50) | Return On Equity |
The market value of PAVmed Inc is measured differently than its book value, which is the value of PAVmed that is recorded on the company's balance sheet. Investors also form their own opinion of PAVmed's value that differs from its market value or its book value, called intrinsic value, which is PAVmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PAVmed's market value can be influenced by many factors that don't directly affect PAVmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PAVmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if PAVmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PAVmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.